InsidersTradesSigma
Follow the Helix BioPharma Corp. share price and the full directors' dealings record of the company, a listed issuer based in Canada. Shares are listed on CA CA, under the authority of SEDI. Operating in the Health Care sector, Helix BioPharma Corp. has published 6 insider filings. Market capitalisation: €56.5m. The latest transaction was disclosed on 4 June 2026 (16 - Acquisition or disposition under a prospectus exemption). Among the most active insiders: Babbar, Rohit. The full history is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
6 of 6 declarations